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Abstract 
Stimulation of secretion from rat alveolar epithelial type il cells by the fl-adrenergic agonist erbutaline activates cAMP-dependem 
protein kinase (PKA). The same secretagogue also activates endogenous protease calpain in type II cells. In this study, we investigated 
the effect of calpain activation on PKA and its phosphorylation activity in stimulated type 11 cells. Type II cells were either pretreated 
with cell-permeable calpain specific inhibitor (N-acetyl-leucyl-leucyl-methioninal) or untreated, and subsequently stimulated with 
terbutaline. Stimulus-induced phosphorylation activity was assayed using the PKA-specific substrate Kemptide. Maximum PKA activity 
was observed within I-3 rain of stimulation. Peak activity of the untreated cells was 20-25% higher and longer than that of the 
inhibitor-treated cells. The stimulus-induced phosphorylation activity of both cell groups was suppres~ble by PKA-specific inhibitor. 
Concomitant photoaffinity labeling with radioactive 8-azido-cAMP revealed that a 39 kDa proteolytic fragment was generated in response 
to stimulation by terbutaline. Stimulus-induced activation of PKA resulted in the phosphorylation of two er, dogenous proteins, p112 and 
p47. Phosphorylation of p112 and p47 was modulated in cells pretreated with calpain inhibitor or in the presence of PKA inhibitor. 
Aggregate r sults indicate that stimulus-induced proteolysis of pKA occurs in type II cells, suggesting that limited proteolysis of PKA by 
endogenous calpain may convert an initial transient signal to sustained and augumented phosphorylation activity for ~cretion. 
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1. Introduction 
Two phenotypically different epithelial cells, type ! and 
II, line the pulmonary alveolus [1]. Type n cells synthesize 
lung surfactant which is stored in lamellar bodiex and 
secreted by exocytosis [2-4]. Previous studies have shown 
that the secretory activity of type II cells can be enhanced 
by various secretagogues such as calcium ionophore, 
parinergic and ~-adrenergic agonists [5,6]. Stimulation of 
type II cells, for example, with the ~-adrenergic receptor 
agonists terbutaline or isoproterenol activates adenylate 
cyclase via G-protein and results in increased cAMP levels 
that activate PKA [7,8]. Activated PKA then phospho- 
rylates specific protein(s) presumably involved in the se- 
cretory processes [9]. Recently we observed that the same 
set of secretagogues also activates endogenous calpain in 
isolated alveolar type It cells [10]. Furthermore, type iI 
cells pretreated with a cell-permeable calpain inhibitor 
exhibited substantially depressed (40-50%) secretory ac- 
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tivities [11]. In this study, therefore, we investigated the 
effect of calpain activation on protein kinase A and its 
phosphorylation activity in alveolar type I1 cells stimulated 
with terbutaline. 
Calpains (EC 3.4.22.17, calcium-activated neutral pro- 
teases) are characterized by their ability, :e perform limited 
proteolysis of specific proteins including protein kinases 
[12]. cAMP-dependent protein kinase (PKA) [13.14], cal- 
cium-phospholipid-dependent protein kinase (PKC) [ 15,16], 
and pp60 ~r~ tyrosine protein kinase (TPK) [17] are cleaved 
by calpain. Proteolytically modified protein kinases are 
functionally altered and can phosphorylate without cofac- 
tors. For example, upon binding cAMP, PKA is activated 
when tts regulatory subunits dissociate from the enzyme. 
The regulatory subunits of PKA are, however, susceptible 
to proteolysis by calpain and can be cleaved into 39 and 17 
kDa fragments [13]. The proteolyzed regulatory subunit is 
then no longer able to reassociate with the catalytic sub- 
units to inhibit them and the enzyme remains activated 
without cAMP [14]. The regulatory fragments, however, 
retain their ability to bind cAMP and can be photolabeled 
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with 8-N~-[ ~'P]cAMP. a photoaffinity analog of" cAMP 
[18,19]. cAMP-binding (35-39 kDa) proteins are produced 
following the endogenous [I 3] or exogenous [20.21] prote- 
olysis of regulatory subunits from both PKA isozymes. 
These fragments are apparently formed in vivo since their 
levels are not reduced following homogenization f tissues 
in the presence of EDTA or other protease inhibitors 
[14.22.23]. Age-dependent changes in the amount of en- 
dogenously proteolyzed PKA regulatory subunits in mouse 
lung are also reported [24], 
In the present study, we investigated whether proteoly- 
sis of PKA by calpain occurs and engenders ustained 
phosphorylation activity in stimulated type II cells. The 
effect of proteolysis on the stimulus-dependent phospho- 
rylation activity of PKA was examined utilizing the col- 
pain inhibitor 11 (N-acetyl-leucyl-leucyl-methioninal). This 
inhibitor is known to possess good membrane penetratabil- 
ity and is a potent inhibitor of calpain [11,25,26]. The 
stimulus-induced proteolysis of PKA was monitored by 
photoaffinity labeling of the proteolyzed fragment. En- 
dogenous proteins pecifically phosphorylated byactivated 
PKA were identified by their responses to calpain or PKA 
inhibitor. 
2. Materials and methods 
All culture material was purchased from GIBCO Labo- 
ratories (Grand Island. NY), [y-3-~P]ATP (2 mCi/ml: 3 
Ci/mmol) and [~z P]orthophosphate (1 mCi/ml) were pur- 
chased from Amersham (Arlington Heights, IL). 8-N 3- 
[3_, P]cAMP (8-azidoadenosine-3'.5'-cyclic monophosphate. 
I mCi/ml; 50 Ci/mmol) and monoclonal anti-actin 
(C4MAb) were purchased from ICN (lrvine, CA). Calpain 
inhibitor II (N-acetyl-leucyl-leucyl-methioninal) was pur- 
chased from Boehringer Mannheim (Indianapolis, IN). 
Kemptide (cAMP-dependent protein kinase substrate. LR- 
RASLG) and phosphocellulose units for PKA assay were 
purchased from Pierce (Rockford, IL). Synthetic AMP- 
dependent protein kinase inhibitor (rabbit sequence 
TTWADFILASGRTGRRDAILHD), terbutaline, charcoal 
(at,,ivated) and other chemicals were from Sigma (St. 
Louis. MO). 
2.1. Isolation of ah'eolar epithelial O'pe H cells and prepa- 
ration ~f c:vtosol fraction 
Alveolar type 11 cells were isolated from rat lung, as 
previously described by Dobbs at al. [27]. Isolated type ii 
cells were plated at 10 million density in 100 mm cell 
culture dishes (Costar). After 18-20 h of culture in mini- 
mal essential medium (MEM) with 10% fetal calf serum 
(FCS) and in air/CO, (19:1), the medium containing 
unattached cells was discarded. Adhering type II cells (3-4 
million. 30% plating efficiency) were equilibrated further 
with fresh MEM without FCS or prcincubated wiih MEM 
containing 10 /zM of calpain inhibitor II for 45-60 min 
before initiation of experiments. 
Inhibitor treated or untreated cells (3-4 million) were 
subsequently stimulated with terbutaline (10 ,aM) for 0, 1, 
2, 3, and 5 min. Control cells (0 rain) had no additions. At 
the end of each incubation period, activated charcoal (0.3 
mg/ml) was added and the medium was quickly removed. 
The cells were wa:,hed twice with ice-cold PBS containing 
I mM EGTA and then scraped gently. Harvested cells 
were pelleled by cemrifugation at 1000 rpm for 10 rain. 
The cell pellet was lysed in 100-150 ,al of ice-cold lysing 
buffer (40 mM Tris, 150 mM NaCI. 2 mM EGTA, 10 mM 
Chaps. I mM PMSF, I0 mM benzamidine, 0.1 mM leu- 
peptin. 0.1% aprotinin. 0.1 ,aM pepstatin, 0.Irk NAN,, pH 
7.0) for 60 rain and further distrupted by sonication 
(Ultrosonicator. Inc., setting 7) for 5 s twice. Cytosolic 
supernate was used for PKA phosphorylation activity de- 
termination and photoaffinity labeling. 
2.2. Assay for phosphorylation actirity of PKA 
A reaction mixture (50/J,I) containing cytosolic fraction 
(30-40 ,ag), MgCI 2 (5 mM), ATP (5 ,aM) and Kemptide 
(40 ,ag) was used for assay of PKA phosphorylation 
activity. For the PKA inhibited samples, synthetic PKA 
inhibitor (10 ,aM) was also included. Alter a 3-min prein- 
cubation, the reaction was started by adding [3"~P]ATP 
(2.5 x 106 cpm). Phosphorylation was terminated after 10 
min by the addition of an equal volume of stopping buffer 
(50 mM Tris, 10 mM NaF, I mM DTr, pH 7.6). The 
reaction mixture was spotted on a phosphocellulose micro- 
centrifuge unit and centrifuged for 30 s. The adhering 
sample was washed with 250 /1,1 of phosphoric acid (75 
mM) and centrifuged. The process was repeated. The 
phosphocelluse unit containing the processed sample was 
transferred into a scintillation vial and counted. 
2.3. Assay for endogemms proteins phosphorylated by 
PKA 
The reaction mixture contained the cytosolic fraction 
and MgCI,. with or without synthetic PKA inhibitor (10 
p,M). The reaction was initiated by adding [~-'P]ATP. 
Following a 10-min incubation, phosphorylation was ter- 
minated by adding solubilizing buffer. The mixture was 
then heated at 100°C for 5 min and subjected to SDS-PAGE 
analysis lbllowed by autoradiography. The radioactivity of 
selected protein bands stained with Coommassie blue was 
scanned by AMBIS. 
2.4. Metabolic htbeling ~f alceolar type H ceils with 
H: P]orthophosphate 
After 1~-20 h of culture in MEM with 10% FCS. type 
II cells plated at I0 million density in 100 mm cell cuture 
dishes were washed with phosphate-deficient MEM l\,r 6 
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times and then incubated with [~ZP]orthophosphate (10 
/xC i /ml )  for 3 h. Labeled cells were either pre-treatcd ~ .,:,: _ 
with 10 /aM calpain inhibitor 11 for 60 min or left un- ~ ~, 
treated. Both types of labeled cells were subsequently o 
stimulated with terbutaline (/.aM) lbr 5 rain. The cells ~ 2 : : -  
were harvested and solubilized in sample buffer and ana- 
lyzed by SDS-PAGE and autoradiography for endoge- ~ 5. 
nously phosphorylated proteins. :'_ 2co 
2.5. Photoaffbti~." labeling of the regtdatory sttlmnit of  
PKA ~ ~: -  
An aliquot (100 p.l, I mg/ml )  of cytosolic fraction was 
placed ip a microtiter plate well containing a small bar ca  ~ : 
magnet. Photolabile radioactive cAMP (8-N~-[ ~-~ P]cAMP. 
1 /aM) was added and incubated for 30 min in the dark at 
room temperature. Photolysis was carried out using a 
UVS-54 mineralight lamp 10 cm from the plate for 15 min 
at room temperature. An aliquot (50 #l )  of  the photolyzed 
sample was injected into an equal volume of 5~ TCA for 
determinat;on of  TCA precipitable radioactivity. Another 
aliquot (50 /zl) was injected into the stopping buffer (50 
mlVl Tris. pH 7.6, 10 mM NaF. 1 mM DT' I )  for analysis of 
photolabeled proteins by SDS-PAGE and autoradiography. 
2.6. Other procedures 
SDS-PAGE was carried out according to Laemmli  [28] mcnt~ 
using 7.5 or 10,% gel. Protein concentrations were deter- 
mined by the method of  Bradford [29] using bovine 3'- 
globulin as a standard. 
3. Resu l ts  
3.1. Effect o f  calpain rm PKA act ir#v in ~.'pe II cells in 
response to stimulation 
To investigate the effect of  stimulus-induced calpain 
activation on the PKA activity in type 11 cells, PKA 
activities of  the cells pretreated with calpain inhibitor were 
compared with their untreated counterparts. Phosphoryla- 
tion activity in the calpain-inhibited cells should represent 
native PKA activity without proteolytic modification. Thus, 
cells were preincubated with cel l -permeable calpain in- 
hibitor II (N-acetyl- leucyl- leucyl-methioninal.  10 ,ttM) for 
45 -60  min prior to stimulation by terbutaline for 0. I. 2, 3. 
and 5 min. The inhibitor concentration and preincubation 
t ime were previously determined by the inhibition of  
[3H]phosphatidylcholine secretion from type II cells prela- 
beled with [3H]choline [1 I] and by inhibition of proteoly- 
sis of  endogenous pectrin in intact type II cells [10] 
PKA activity of  the cytosol fraction was assayed using 
PKA-specif ic substrate (synthetic peptide, Kemptide). Fig. 
1 indicates that PKA activity rises to a max imum within 
1-2 min and thereafter declines during 3 -5  min of  stimu- 
3 7 2 3 a 5 
Time (min) 
Fig. I. The cllccl ,ff calpain inhibition on the stimulus-induced PKA 
pho~,phor~,l,,li,m ,cli,.it) in alveolar epithelial type n cells. Cells ',,.ere 
either pretreated :'.ith calpain inhibitor I1 (N-acetyl-leucyl-leucyi-meth- 
ioninal. II) #M) lor 45-60 min or left untreated. Both types of cells were 
then ,timulatcd '.,.ith tcrbutaline ( I0/aM) for 0. I. 2.3.5 rain. Cell lysate 
(30-40/zg) '.'.a~ a,,,a'.ed for PKA acti'.ily ,asing Kemptide (40 #g) as the 
,ub-trate v. ith or v. ithout s.'. nthetic PKA inhibitor ( I0 #M) as, de:~,cibed in 
Sccdon 2. [ '-" P] incorporation {pmol/mg protein) wa: ~, plotted a~. lunction 
of qimulatioll time. ~. Untreated cells: A. assayed in the presence of 
PKA inhibitor: O. cells pre-treated with calpain inhibitor; z~. assayed in 
the pre,encc of PKA inhibitor. Values are means±S.E, of 4-6 experi- 
97 - 
'14-  
1 2 3 4 
Fig. 2 Photoatlinit) labeling of PKA regulatoo ~,uhunits in type n cells. 
Acti'~atcd charcoal treated cell ly:.,ate fi'om type II cells stimulated with 
terhutaline t 10 /z~.l~ Ibr 0. 2. 3 min were photoaffinity-labeled v, ith 
;-;-azido-cAMP ( I p..M) as described in Section 2. A: TCA precipitable 
radioacti~il.~. Aliquot of photolysed mixture was precipitated by equal 
,.olume 5c~ - "[CA and counts of the precipitate ~erc plotted as function of 
~timulation time. Values sho'.,,n are averages of tv, o experiments. B:
Photolabeled prolcm~. Aliquot of photolabeled mixture was analyzed by 
SDS-PAGE (7.5'~ gel) t'~llowed by autoradiography. Lane I. unstimu- 
lated celh,: lane 2. 2 rain: lane 3. 3 rain r.timulated cells: lane 4. calpain 
inhibited ,:cll~. 
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Fig. 3. Endogenous proteins phosphorylated by PKA in type II cells 
stimulated b) terbutaline. Cells v.ere stimulated with terbutaline for O, 1. 
2. 3 min. Cytosolic fractions (30 /zg) in lysing bufl~r (see Section 2) 
were incubated with MgCI. (5 raM) and ATP (5 /.tM). For the PKA-in- 
hibited samples, ynthetic PKA inhibitor ~ I0 ~M) was also present. Alter 
3 min preincubation, the reactkm was stalled by addition of [~" PIATP 
(2.5×10 ~ cpml. After 10 min incubation, the reaction mixture was 
directly solubilized in sample buffer and analyzed by SDS-PAGE (7.5cb 
gel) followed by autoradi[zraphy. Lanes (I-4): 0. 1.2.3 min stimulatnon. 
I~mes (5-8k O. I. 2. 3 min stimulation and assayed in the presence of 
PKA inhibitor. 
lation (n = 6), Protracted stimulation of 30-60  min yielded 
no delayed additional activity. The initial PKA activity of 
unstimulated cells (200 pmol/mg protein) increased 1.5- 
2.0 fold (367 pmol/mg), reaching a maximum at 2 min 
declining to half (260 pmol/mg) by 3-5 rain. The rise and 
fall of PKA activation was also observed in the calpain-in- 
hibited cells except that maximum activity occurred con- 
sistently earlier (I min) and was 22-25% lower than the 
untreated cells (n = 6). When synthetic PKA inhibitor was 
included in the assay mixture, stimulus-dependent modula- 
tion of phosphorylation activities was absent and was 
70-75% less than the maximum activity of either un- 
treated or inhibited cells. The data suggest hat stimulation 
of type II cells with terbutaline activates calpaiu and PKA, 
and that calpain up-regulates maximal PKA activity for 
10-15% and prolongs it relative to calpain-inhibited cells. 
3.2. Tke st imuhts- in&. 'ed proteolysis o f  PKA in ~'pe H 
cells 
Previous study indicated that trypsin (or an endogenous 
calcium-dependent protease during purification) cleaved 
the regulatory subunit of PKA isozyme II and generated a 
distinctive 39 kDa fragment which is still able to bind 
cAMP [13]. To confirm the limited proteolysis of PKA in 
type II cells in response to stimulation, the appearance of 
this fragment was monitored by photoaffinlty labeling. The 
fragment was covalently labeled wdh a photolabile ana- 
logue of radioactive cAMP. 8-azido-cyclic-[ ~2 P]AMP. The 
fragment binds photolabel with high affinity (125-200 
nM) and exhibits the same binding characteristics a cAMP 
[30]. Photolysis of 8-N-[ 32 P]cAMP by UV (245 nm) gener- 
ates a nitrene group which ~:an react with any amino acid 
residues within its binding site. 
Isolated type II cells (3 -4  mil l ion/plate) were stimu- 
lated with terbutaline (10 ~M)  for 0. 2 or 3 rain. The 
cytosolic fractions were then preincubated with 8-N 3- 
[3:p]cAMP (I g,M) for 30 rain in the dark and subse- 
quently photolyzed using a UVS-54 mineralight lamp for 
IO rain (see Section 2). Aliquots were withdrawn for the 
determination of TCA precipitable incorporation of ra- 
dioactive photolable and for analysis of the photolabeled 
proteins by SDS-PAGE and autoradiography. Fig. 2A indi- 
cates that TCA precipitable radioactivity increased uring 
the first 2 -3  min of stimulation. 
Analysis of the photolabeled proteins by SDS-PAGE 
and autoradiography revealed that in the unstimulated cell 
lysate, the PKA regulatory subunit type 1 (RI, 49 kDa) 
alone was heavily photolabeled, while the regulatory sub- 
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Fig. 4. The effect of calpain inhibition on the phosphorylation of endoge- 
nous proteins in type II cells stimulated by terbutaline. Cells were either 
pre-treated with calpain inhibitor 11 (10 #M) far 60 min or left untreated. 
Both type of cells were then stimulated with lerbutaline (IO /.tM) for 0, I, 
2.3 rain. Cytosolic fractions t60/,~g) was incubated with phosphorylation 
reaction mixture and processed as described in Fig. 3 legend. Lanes 
( I-4): 0, I. 2, 3 rain stimulation ofuntreated ceils. Lanes (5-8): 0,1, 2, 3 
rain stimulation ofcalFain-inhlbited cells. 
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Fig. 5. In vivo phosphoo'lation fendogenou,~ proteins in phosphorous-32 
labeled alveolar type 11 cells stimulated with terbutaline, lsohacd type II 
cells were labeled with [~:Plorthophosphate (IO p-Ci/n'd) for 3 h. 
Labeled cells were either pre-treated with calpain inhibitor 11 ( 10 ~M) for 
60 min or left untreated. Both types of labeled cells were subsequentl? 
stimulated with terbutaline (10 p,M) for 5 min. Cell~, v.ere harse~ted. 
solnbilized in sample buffer and analyzed by ~DS-PAGE and autoradiog- 
raphy. The radioactivities in p112 and 1347 protein hands '.','ere scanned by 
AMBIS and plotted. (I) Unstimuluted cells. (2) (erbutuline-stimulated 
cells. (3) cells pre-treated with calpain inhibitor and then stimulated with 
terbutaline. 
unit type II (RII, 56 kDa) and a proteolytic fragment of  R 
(39 kDa) were only faintly photolabeled. In the stimulated 
cells, however,  all three were intensely photolabeled. In 
addition, a 45 and 43 kDa doublet and a 33 kDa protein 
were also labeled (Fig. 2B). A radioscan indicated that 
photolabeling of  the 39 kDa fragment increased 6- to 
8-fold in the stimulated cells (n = 2). The results indicate 
that PKA is subject to proteolysis in type 11 cells in 
response to stimulation and that proteolysis is complete 
within 2 -3  min. 
3.3. Endoeemms prote ins  phosphory la ted  by PKA in O'pe 
]I ce l ls  in response  to st imulat ion 
To identify the endogenous proteins phosphorylated by 
PKA in response to stimulation, the standard PKA assay 
was carried out without Kemptide. Assays were also per- 
formed ~ith and without synthetic PKA inhibitor. The 
samples were subjected to SDS-PAGE and auloradiog- 
raphy. From visual estimates of  the intensity of  phospho- 
r vlated protein hands, two proteins with electrophoretic 
mobility corresponding to 112 and and 47 kDa were 
judged to be the endogenous ubstrates of  PKA. The 
stimulus-dependent phosphor3,1ation kinetics of  these pro- 
teins was ( I )  similar to the activity profile observed in 
vitro (Fig. 3. lanes I -4  and Fig. 4. lanes I -4 ) .  (2) 
abolished when PKA inhibitor was present (Fig. 3. lanes 
5-8) .  and (3) modulated when calpain inhibitor was pre- 
sent (Fig. 4. lanes 5-8) .  Furthermore, when endogenous 
phospho~,lation of 3:P metabolically labeled cells was 
examined, proteins (104, 138. I I0 ,  84. 73, 53, 47, 40 and 
29 kDa) were phosphorylated in response to a 5-min 
slimulaTitm xsith terbutaline. Among these proteins, p110 
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Fi~. 6. Endogenott~ proteins phosphorylated in type II cells stimulated by 
terbulatine and l~.,a',ed in the presence of exogenous cAMP. Cell lysate 
from cell, stimulated with terbutaline for O, I. 2. 3 min was assayed for 
PKA activity in the presence of cAMP (10 /zM) and analyzed by 
SDS-PAGE ( 10% gel) followed by autonldiogruphy. Lanes ( I ) 0 rain. (2) 
I min. (~) 2 min. (4) 3 min. 
and p47 showed 20-25c/~ reduced phosphorylation i  cal- 
pain-inhibited cells relative to uninhibited cells (Fig. 5). 
The specificity of the endogenous proteins phosphorylated 
by PKA was further demonstrated by a PKA assay in 
which exogenous cAMP (I /.tM) was added. Under this 
condition, the phospho"vlation f p47 was highly enhanced 
relative to the other proteins (Fig. 6). Thus. the p47 protein 
appears to bt: the major target of activated PKA in type II 
cells in response to stimulation by terbutaline. 
4. Discussion 
Enhanced secretory activity of alveolar epithelial type I1 
cells is associated with an increased intracellular cAMP (or 
calcium) concentration and activation of protein kinase 
PKA (or PKC). Intracellulal cAMP (or calcium), however, 
rises only transiently, whereas observable nhanced secre- 
tion occurs much later at 1-2 h [5]. How the transient rise 
in the second messengers and subsequent activation of 
protein kinases relate to the augmcoted secretory activity 
of type II cells over longer time periods remains obscure. 
Furthermore. the cellular proteins phosphorylated by acti- 
vated protein kinase have not been well characterized an~ t 
their exact role in the secretory activity of type 11 cells is 
presently unknown. 
In contrast o neurotransmitier r lease or platelet activa- 
tion. stimulated secretion of type I1 cells is a relatively 
slow and protracted process that may require the sustained 
elevation of second messenger or signal-transducer activ- 
ity. It is not known whether the process is effected by a 
prolonged protein kinase activity or by multiple repetitive 
activations in time. We examined therefore whether the 
limited proteolysis of PKA by activated calpain might 
provide a plausible mechanism for sustained augumenta- 
tion of secretion. Proteolytically modified PKA is known 
to remain activated without initial activating cofactor cAMP 
[141. 
The results of our photoaffinity labeling experiment 
indicate that limited proteolysis of PKA indeed takes place 
in type II cells in response to stimulation. It has been 
shown that trypsin treatment of purified PKA regulatory 
subunits R I (49 kDa) and R n (56 kDa) results in 37 and 39 
kDa fragments, respectively [211. To our knowledge, a 
comparable study using calpain has not been done. In our 
own cell system, however, other protein bands between 49 
and 39 kDa are also photolabeled. In addition, the photola- 
beling of the full-length regulatory subunits (56 and 49 
kDa) increases in spite of increased proteolysis in response 
to stimulation. The reason for enhanced photolabeling of 
the full-length regulatory subunits is not clear. It has been 
shown that regulatory subunits exist in either holoenzyme 
form or dissociated state, and that the relative proportion 
of each may change, for example, with age [24]. A stochas- 
tic change in proportionality in response to stimulation 
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may favor the dissociated subunit with higher affinity for 
cAMP and thereby result in increased photolabeling. 
In parallel with proteolysis, PKA activity appears to be 
sustained at elevated levels longer than calpain-inhibited 
cells. The peak activities of both cell groups are neverthe- 
less transient, leveling off after 5 rain of stimulation with 
no later peaks. Hence. our results suggest hat secretory 
activity of type II cells is sustained by continuous aug- 
mented activation rather than multiple repetitive activation 
by PKA. 
The proteins p112 and p47 proteins specifically phos- 
phorylated by PKA in response to stimulation are potential 
signal transducers for type II cell secretion. In view of the 
highly enhanced phosphorylation of p47 protein in the 
presence of exogenous cAMP. it appears to be the pre- 
ferred substrate of PKA. Our preliminary studies by im- 
munoblot with monoclonal antibody anti-actin followed by 
autoradiography, however, suggest hat the p47 protein is 
not an actin molecule. Under our experimental conditions. 
actin itself was not phosphorylated in type It cells in 
response to terbutaline, in contrast to a previous study 
reporting cAMP-dependent phosphorylation of actin in 
type II cells [9]. In conclusion, stimulus-induced PKA 
activity is up-regulated and sustained by calpain. The 
target of PKA activity appears to he two proteins, p112 
and p47. The identity of these proteins remains to be 
elucidated. 
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